ICON Public Limited Company IJF.F Stock
ICON Public Limited Company Price Chart
ICON Public Limited Company IJF.F Financial and Trading Overview
ICON Public Limited Company stock price | 290.3 EUR |
Previous Close | 212.5 EUR |
Open | 211.3 EUR |
Bid | 211.6 EUR x 6000 |
Ask | 215.6 EUR x 5000 |
Day's Range | 211.3 - 211.3 EUR |
52 Week Range | 162.75 - 242 EUR |
Volume | 30 EUR |
Avg. Volume | 25 EUR |
Market Cap | 17.39B EUR |
Beta (5Y Monthly) | 1.10669 |
PE Ratio (TTM) | 35.874363 |
EPS (TTM) | 6.91 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
IJF.F Valuation Measures
Enterprise Value | 21.81B EUR |
Trailing P/E | 35.874363 |
Forward P/E | 19.087626 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.2245095 |
Price/Book (mrq) | 2.0004356 |
Enterprise Value/Revenue | 2.79 |
Enterprise Value/EBITDA | 14.632 |
Trading Information
ICON Public Limited Company Stock Price History
Beta (5Y Monthly) | 1.10669 |
52-Week Change | 14.35% |
S&P500 52-Week Change | 20.43% |
52 Week High | 242 EUR |
52 Week Low | 162.75 EUR |
50-Day Moving Average | 188.22 EUR |
200-Day Moving Average | 197.39 EUR |
IJF.F Share Statistics
Avg. Volume (3 month) | 25 EUR |
Avg. Daily Volume (10-Days) | 16 EUR |
Shares Outstanding | 81.93M |
Float | 81.33M |
Short Ratio | N/A |
% Held by Insiders | 0.71% |
% Held by Institutions | 98.16% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.52% |
Operating Margin (ttm) | 11.73% |
Gross Margin | 29.16% |
EBITDA Margin | 19.06% |
Management Effectiveness
Return on Assets (ttm) | 3.32% |
Return on Equity (ttm) | 6.09% |
Income Statement
Revenue (ttm) | 7.82B EUR |
Revenue Per Share (ttm) | 95.8 EUR |
Quarterly Revenue Growth (yoy) | 4.00% |
Gross Profit (ttm) | 2.22B EUR |
EBITDA | 1.49B EUR |
Net Income Avi to Common (ttm) | 509.99M EUR |
Diluted EPS (ttm) | 5.89 |
Quarterly Earnings Growth (yoy) | 4.20% |
Balance Sheet
Total Cash (mrq) | 281.53M EUR |
Total Cash Per Share (mrq) | 3.44 EUR |
Total Debt (mrq) | 4.67B EUR |
Total Debt/Equity (mrq) | 53.91 EUR |
Current Ratio (mrq) | 1.183 |
Book Value Per Share (mrq) | 105.627 |
Cash Flow Statement
Operating Cash Flow (ttm) | 511.9M EUR |
Levered Free Cash Flow (ttm) | 354.96M EUR |
Profile of ICON Public Limited Company
Country | Germany |
State | N/A |
City | Dublin |
Address | South County Business Park |
ZIP | 18 |
Phone | 353 1 291 2000 |
Website | https://www.iconplc.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 41150 |
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; and clinical research services, including biostatistics, clinical operations, clinical supplies management, covid-19, data management, decentralized & hybrid clinical solutions, endpoint adjudication services, interactive response technologies, investigator payments, medical affairs, medical writing and publishing, pharmacovigilance, and site and patient solutions. The company also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. In addition, it offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Q&A For ICON Public Limited Company Stock
What is a current IJF.F stock price?
ICON Public Limited Company IJF.F stock price today per share is 290.3 EUR.
How to purchase ICON Public Limited Company stock?
You can buy IJF.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ICON Public Limited Company?
The stock symbol or ticker of ICON Public Limited Company is IJF.F.
Which industry does the ICON Public Limited Company company belong to?
The ICON Public Limited Company industry is Diagnostics & Research.
How many shares does ICON Public Limited Company have in circulation?
The max supply of ICON Public Limited Company shares is 82.5M.
What is ICON Public Limited Company Price to Earnings Ratio (PE Ratio)?
ICON Public Limited Company PE Ratio is 42.01157800 now.
What was ICON Public Limited Company earnings per share over the trailing 12 months (TTM)?
ICON Public Limited Company EPS is 6.91 EUR over the trailing 12 months.
Which sector does the ICON Public Limited Company company belong to?
The ICON Public Limited Company sector is Healthcare.